{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T22:29:37Z","timestamp":1791584977659,"version":"4.3.4"},"reference-count":27,"publisher":"American Medical Association (AMA)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2014,2,19]]},"DOI":"10.1001\/jama.2014.467","type":"journal-article","created":{"date-parts":[[2014,2,18]],"date-time":"2014-02-18T21:31:20Z","timestamp":1392759080000},"page":"692","source":"Crossref","is-referenced-by-count":598,"title":["Radiofrequency Ablation vs Antiarrhythmic Drugs as First-Line Treatment of Paroxysmal Atrial Fibrillation (RAAFT-2)"],"prefix":"10.1001","volume":"311","author":[{"given":"Carlos A.","family":"Morillo","sequence":"first","affiliation":[{"name":"McMaster University, Population Health Research Institute, Hamilton Health Sciences, Hamilton, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atul","family":"Verma","sequence":"additional","affiliation":[{"name":"Southlake Regional Health Centre, Newmarket, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart J.","family":"Connolly","sequence":"additional","affiliation":[{"name":"McMaster University, Population Health Research Institute, Hamilton Health Sciences, Hamilton, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl H.","family":"Kuck","sequence":"additional","affiliation":[{"name":"Asklepios Klinik St Georg, Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Girish M.","family":"Nair","sequence":"additional","affiliation":[{"name":"Ottawa Heart Institute, Ottawa, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Champagne","sequence":"additional","affiliation":[{"name":"Universite Laval, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence D.","family":"Sterns","sequence":"additional","affiliation":[{"name":"Victoria Cardiac Arrhythmia Trials Inc, Victoria, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Beresh","sequence":"additional","affiliation":[{"name":"McMaster University, Population Health Research Institute, Hamilton Health Sciences, Hamilton, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey S.","family":"Healey","sequence":"additional","affiliation":[{"name":"McMaster University, Population Health Research Institute, Hamilton Health Sciences, Hamilton, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Natale","sequence":"additional","affiliation":[{"name":"St Davids Medical Center, Austin, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"RAAFT-2 Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"4","key":"joi140008r1","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1016\/j.jacc.2006.07.009","article-title":"ACC\/AHA\/ESC 2006 guidelines for the management of patients with atrial fibrillation\u2013executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation).","volume":"48","author":"Fuster","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"joi140008r2","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1161\/01.CIR.98.10.946","article-title":"Impact of atrial fibrillation on the risk of death: the Framingham Heart Study.","volume":"98","author":"Benjamin","year":"1998","journal-title":"Circulation"},{"key":"joi140008r3","doi-asserted-by":"publisher","first-page":"2920","DOI":"10.1161\/01.CIR.0000072767.89944.6E","article-title":"Temporal relations of atrial fibrillation and heart failure and their joint influence on mortality.","volume":"107","author":"Wang","year":"2003","journal-title":"Circulation"},{"issue":"6","key":"joi140008r4","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1067\/mhj.2002.122518","article-title":"Quality of life improves with treatment in the Canadian Trial of Atrial Fibrillation.","volume":"143","author":"Dorian","year":"2002","journal-title":"Am Heart J"},{"issue":"4","key":"joi140008r5","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.jacc.2006.03.051","article-title":"Quality of life and exercise performance in patients in sinus rhythm versus persistent atrial fibrillation: a Veterans Affairs Cooperative Studies Program Substudy.","volume":"48","author":"Singh","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"joi140008r6","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.cjca.2012.01.021","article-title":"Focused 2012 update of the Canadian Cardiovascular Society atrial fibrillation guidelines: recommendations for stroke prevention and rate\/rhythm control.","volume":"28","author":"Skanes","year":"2012","journal-title":"Can J Cardiol"},{"issue":"6","key":"joi140008r7","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1093\/europace\/eum120","article-title":"HRS\/EHRA\/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation developed in partnership with the European Heart Rhythm Association (EHRA) and the European Cardiac Arrhythmia Society (ECAS); in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), and the Society of Thoracic Surgeons (STS). Endorsed and approved by the governing bodies of the American College of Cardiology, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, and the Heart Rhythm Society.","volume":"9","author":"Calkins","year":"2007","journal-title":"Europace"},{"issue":"4","key":"joi140008r8","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1161\/CIRCEP.108.824789","article-title":"Treatment of atrial fibrillation with antiarrhythmic drugs or radiofrequency ablation: two systematic literature reviews and meta-analyses.","volume":"2","author":"Calkins","year":"2009","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"21","key":"joi140008r9","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1093\/eurheartj\/ehs253","article-title":"2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association.","volume":"33","author":"Camm","year":"2012","journal-title":"Eur Heart J"},{"issue":"24","key":"joi140008r10","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1161\/CIRCULATIONAHA.108.772582","article-title":"Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study [published correction appeared in Circulation 2009;120:e83].","volume":"118","author":"Ja\u00efs","year":"2008","journal-title":"Circulation"},{"issue":"11","key":"joi140008r11","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1016\/j.jacc.2006.08.037","article-title":"A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study.","volume":"48","author":"Pappone","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"joi140008r12","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1093\/eurheartj\/ehi583","article-title":"Catheter ablation treatment in patients with drug-refractory atrial fibrillation: a prospective, multi-centre, randomized, controlled study.","volume":"27","author":"Stabile","year":"2006","journal-title":"Eur Heart J"},{"issue":"4","key":"joi140008r13","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1001\/jama.2009.2029","article-title":"Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial.","volume":"303","author":"Wilber","year":"2010","journal-title":"JAMA"},{"issue":"2","key":"joi140008r14","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1111\/jce.2009.20.issue-2","article-title":"A systematic review of randomized trials comparing radiofrequency ablation with antiarrhythmic medications in patients with atrial fibrillation.","volume":"20","author":"Nair","year":"2009","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"1","key":"joi140008r15","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1080\/14017430701798838","article-title":"Curative ablation for atrial fibrillation: a systematic review.","volume":"42","author":"Gjesdal","year":"2008","journal-title":"Scand Cardiovasc J"},{"issue":"21","key":"joi140008r16","doi-asserted-by":"publisher","first-page":"2634","DOI":"10.1001\/jama.293.21.2634","article-title":"Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial.","volume":"293","author":"Wazni","year":"2005","journal-title":"JAMA"},{"issue":"17","key":"joi140008r17","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1056\/NEJMoa1113566","article-title":"Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation.","volume":"367","author":"Cosedis Nielsen","year":"2012","journal-title":"N Engl J Med"},{"issue":"5","key":"joi140008r18","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.hrthm.2010.01.021","article-title":"Circumferential pulmonary vein ablation: does use of a circular mapping catheter improve results? a prospective randomized study.","volume":"7","author":"Tamborero","year":"2010","journal-title":"Heart Rhythm"},{"issue":"3","key":"joi140008r19","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","article-title":"EuroQol\u2013a new facility for the measurement of health-related quality of life.","volume":"16","author":"EuroQol Group","year":"1990","journal-title":"Health Policy"},{"key":"joi140008r21","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1214\/aos\/1176345976","article-title":"Cox\u2019s regression model for counting processes: a large sample study.","volume":"10","author":"Andersen","year":"1982","journal-title":"Ann Stat"},{"issue":"3","key":"joi140008r22","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1161\/CIRCULATIONAHA.104.518837","article-title":"Perception of atrial fibrillation before and after radiofrequency catheter ablation: relevance of asymptomatic arrhythmia recurrence.","volume":"112","author":"Hindricks","year":"2005","journal-title":"Circulation"},{"issue":"6","key":"joi140008r23","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1161\/CIRCEP.111.966408","article-title":"Radiofrequency catheter ablation and antiarrhythmic drug therapy: a prospective, randomized, 4-year follow-up trial: the APAF study.","volume":"4","author":"Pappone","year":"2011","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"2","key":"joi140008r24","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s10840-012-9721-2","article-title":"Health-related quality of life questionnaires: an important method to evaluate patient outcomes in atrial fibrillation ablation.","volume":"36","author":"Ha","year":"2013","journal-title":"J Interv Card Electrophysiol"},{"issue":"1","key":"joi140008r25","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1161\/CIRCEP.109.859116","article-title":"Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation.","volume":"3","author":"Cappato","year":"2010","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"9","key":"joi140008r26","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1111\/jce.2009.20.issue-9","article-title":"Complications of atrial fibrillation ablation in a high-volume center in 1000 procedures: still cause for concern?","volume":"20","author":"Dagres","year":"2009","journal-title":"J Cardiovasc Electrophysiol"},{"key":"joi140008r27","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1001\/jamainternmed.2013.1561","article-title":"Discerning the Incidence of Symptomatic and Asymptomatic Episodes of Atrial Fibrillation (AF) Pre- and Post-Radiofrequency AF Ablation (DISCERN AF): A Prospective, Multicenter Study.","volume":"173","author":"Verma","year":"2013","journal-title":"JAMA Intern Med"},{"key":"joi140008r20","volume-title":"EQ-5D Value Sets: Inventory, Comparative Eview and User Guide","author":"EuroQol Group","year":"2007"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/1829990\/jama_morillo_2014_oi_140008_1627317962.10699.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,27]],"date-time":"2021-07-27T12:29:43Z","timestamp":1627388983000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/1829990"}},"subtitle":["A Randomized Trial"],"short-title":[],"issued":{"date-parts":[[2014,2,19]]},"references-count":27,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014,2,19]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2014.467","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718281827.793492315","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.718281827.793491622","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.718281827.793508734","asserted-by":"object"}]},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2,19]]}}}